img

Global Expression Competent Cells Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Expression Competent Cells Market Research Report 2024

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.
According to MRAResearch’s new survey, global Expression Competent Cells market is projected to reach US$ 746.9 million in 2033, increasing from US$ 382.5 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Expression Competent Cells market research.
Key companies engaged in the Expression Competent Cells industry include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Expression Competent Cells were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Expression Competent Cells market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Expression Competent Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Chemically Competent Cells
Electrocompetent Cells

Segment by Application


Protein Expression
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Expression Competent Cells report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expression Competent Cells Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Expression Competent Cells Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Protein Expression
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Expression Competent Cells Market Perspective (2018-2033)
2.2 Expression Competent Cells Growth Trends by Region
2.2.1 Global Expression Competent Cells Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Expression Competent Cells Historic Market Size by Region (2018-2023)
2.2.3 Expression Competent Cells Forecasted Market Size by Region (2024-2033)
2.3 Expression Competent Cells Market Dynamics
2.3.1 Expression Competent Cells Industry Trends
2.3.2 Expression Competent Cells Market Drivers
2.3.3 Expression Competent Cells Market Challenges
2.3.4 Expression Competent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Expression Competent Cells Players by Revenue
3.1.1 Global Top Expression Competent Cells Players by Revenue (2018-2023)
3.1.2 Global Expression Competent Cells Revenue Market Share by Players (2018-2023)
3.2 Global Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Expression Competent Cells Revenue
3.4 Global Expression Competent Cells Market Concentration Ratio
3.4.1 Global Expression Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expression Competent Cells Revenue in 2022
3.5 Expression Competent Cells Key Players Head office and Area Served
3.6 Key Players Expression Competent Cells Product Solution and Service
3.7 Date of Enter into Expression Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Expression Competent Cells Breakdown Data by Type
4.1 Global Expression Competent Cells Historic Market Size by Type (2018-2023)
4.2 Global Expression Competent Cells Forecasted Market Size by Type (2024-2033)
5 Expression Competent Cells Breakdown Data by Application
5.1 Global Expression Competent Cells Historic Market Size by Application (2018-2023)
5.2 Global Expression Competent Cells Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Expression Competent Cells Market Size (2018-2033)
6.2 North America Expression Competent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Expression Competent Cells Market Size by Country (2018-2023)
6.4 North America Expression Competent Cells Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Expression Competent Cells Market Size (2018-2033)
7.2 Europe Expression Competent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Expression Competent Cells Market Size by Country (2018-2023)
7.4 Europe Expression Competent Cells Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Expression Competent Cells Market Size (2018-2033)
8.2 Asia-Pacific Expression Competent Cells Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Expression Competent Cells Market Size by Region (2018-2023)
8.4 Asia-Pacific Expression Competent Cells Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Expression Competent Cells Market Size (2018-2033)
9.2 Latin America Expression Competent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Expression Competent Cells Market Size by Country (2018-2023)
9.4 Latin America Expression Competent Cells Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Expression Competent Cells Market Size (2018-2033)
10.2 Middle East & Africa Expression Competent Cells Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Expression Competent Cells Market Size by Country (2018-2023)
10.4 Middle East & Africa Expression Competent Cells Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expression Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expression Competent Cells Business (2018-2023)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expression Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expression Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expression Competent Cells Business (2018-2023)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Detail
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expression Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expression Competent Cells Business (2018-2023)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Detail
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expression Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expression Competent Cells Business (2018-2023)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Detail
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expression Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2018-2023)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Detail
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expression Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expression Competent Cells Business (2018-2023)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Detail
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expression Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expression Competent Cells Business (2018-2023)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Detail
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expression Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expression Competent Cells Business (2018-2023)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Detail
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expression Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expression Competent Cells Business (2018-2023)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Detail
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Expression Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Expression Competent Cells Business (2018-2023)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Detail
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Expression Competent Cells Introduction
11.12.4 Lucigen Revenue in Expression Competent Cells Business (2018-2023)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Detail
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Expression Competent Cells Introduction
11.13.4 Zymo Research Revenue in Expression Competent Cells Business (2018-2023)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Detail
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Expression Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Detail
11.15.2 Bioline Business Overview
11.15.3 Bioline Expression Competent Cells Introduction
11.15.4 Bioline Revenue in Expression Competent Cells Business (2018-2023)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Detail
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Expression Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Expression Competent Cells Business (2018-2023)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Detail
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Expression Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Expression Competent Cells Business (2018-2023)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Detail
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Expression Competent Cells Introduction
11.18.4 Cell Applications Revenue in Expression Competent Cells Business (2018-2023)
11.18.5 Cell Applications Recent Development
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Detail
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Expression Competent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Expression Competent Cells Business (2018-2023)
11.19.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Detail
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Expression Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Expression Competent Cells Business (2018-2023)
11.20.5 Scarab Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Expression Competent Cells Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Expression Competent Cells Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Expression Competent Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Expression Competent Cells Market Share by Region (2018-2023)
Table 8. Global Expression Competent Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Expression Competent Cells Market Share by Region (2024-2033)
Table 10. Expression Competent Cells Market Trends
Table 11. Expression Competent Cells Market Drivers
Table 12. Expression Competent Cells Market Challenges
Table 13. Expression Competent Cells Market Restraints
Table 14. Global Expression Competent Cells Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Expression Competent Cells Market Share by Players (2018-2023)
Table 16. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
Table 17. Ranking of Global Top Expression Competent Cells Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Expression Competent Cells Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Expression Competent Cells Product Solution and Service
Table 21. Date of Enter into Expression Competent Cells Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Expression Competent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Expression Competent Cells Revenue Market Share by Type (2018-2023)
Table 25. Global Expression Competent Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Expression Competent Cells Revenue Market Share by Type (2024-2033)
Table 27. Global Expression Competent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Expression Competent Cells Revenue Market Share by Application (2018-2023)
Table 29. Global Expression Competent Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Expression Competent Cells Revenue Market Share by Application (2024-2033)
Table 31. North America Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Expression Competent Cells Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Expression Competent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Expression Competent Cells Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Expression Competent Cells Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Expression Competent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Expression Competent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck KGaA Company Detail
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Expression Competent Cells Product
Table 49. Merck KGaA Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Expression Competent Cells Product
Table 54. Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Agilent Technologies Company Detail
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Expression Competent Cells Product
Table 59. Agilent Technologies Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 60. Agilent Technologies Recent Development
Table 61. Takara Bio Company Detail
Table 62. Takara Bio Business Overview
Table 63. Takara Bio Expression Competent Cells Product
Table 64. Takara Bio Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 65. Takara Bio Recent Development
Table 66. Promega Corporation Company Detail
Table 67. Promega Corporation Business Overview
Table 68. Promega Corporation Expression Competent Cells Product
Table 69. Promega Corporation Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 70. Promega Corporation Recent Development
Table 71. Beijing TransGen Biotech Company Detail
Table 72. Beijing TransGen Biotech Business Overview
Table 73. Beijing TransGen Biotech Expression Competent Cells Product
Table 74. Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 75. Beijing TransGen Biotech Recent Development
Table 76. GeneScript Corporation Company Detail
Table 77. GeneScript Corporation Business Overview
Table 78. GeneScript Corporation Expression Competent Cells Product
Table 79. GeneScript Corporation Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 80. GeneScript Corporation Recent Development
Table 81. Yeastern Biotech Company Detail
Table 82. Yeastern Biotech Business Overview
Table 83. Yeastern Biotech Expression Competent Cells Product
Table 84. Yeastern Biotech Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 85. Yeastern Biotech Recent Development
Table 86. New England Biolabs Company Detail
Table 87. New England Biolabs Business Overview
Table 88. New England Biolabs Expression Competent Cells Product
Table 89. New England Biolabs Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 90. New England Biolabs Recent Development
Table 91. QIAGEN N.V. Company Detail
Table 92. QIAGEN N.V. Business Overview
Table 93. QIAGEN N.V. Expression Competent Cells Product
Table 94. QIAGEN N.V. Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 95. QIAGEN N.V. Recent Development
Table 96. OriGene Technologies Company Detail
Table 97. OriGene Technologies Business Overview
Table 98. OriGene Technologies Expression Competent Cells Product
Table 99. OriGene Technologies Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 100. OriGene Technologies Recent Development
Table 101. Lucigen Company Detail
Table 102. Lucigen Business Overview
Table 103. Lucigen Expression Competent Cells Product
Table 104. Lucigen Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 105. Lucigen Recent Development
Table 106. Zymo Research Company Detail
Table 107. Zymo Research Business Overview
Table 108. Zymo Research Expression Competent Cells Product
Table 109. Zymo Research Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 110. Zymo Research Recent Development
Table 111. Bio-Rad Laboratories Company Detail
Table 112. Bio-Rad Laboratories Business Overview
Table 113. Bio-Rad Laboratories Expression Competent Cells Product
Table 114. Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 115. Bio-Rad Laboratories Recent Development
Table 116. Bioline Company Detail
Table 117. Bioline Business Overview
Table 118. Bioline Expression Competent Cells Product
Table 119. Bioline Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 120. Bioline Recent Development
Table 121. Delphi Genetics Company Detail
Table 122. Delphi Genetics Business Overview
Table 123. Delphi Genetics Expression Competent Cells Product
Table 124. Delphi Genetics Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 125. Delphi Genetics Recent Development
Table 126. IBA GmBH Company Detail
Table 127. IBA GmBH Business Overview
Table 128. IBA GmBH Expression Competent Cells Product
Table 129. IBA GmBH Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 130. IBA GmBH Recent Development
Table 131. Cell Applications Company Detail
Table 132. Cell Applications Business Overview
Table 133. Cell Applications Expression Competent Cells Product
Table 134. Cell Applications Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 135. Cell Applications Recent Development
Table 136. BioDynamics Laboratory Company Detail
Table 137. BioDynamics Laboratory Business Overview
Table 138. BioDynamics Laboratory Expression Competent Cells Product
Table 139. BioDynamics Laboratory Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 140. BioDynamics Laboratory Recent Development
Table 141. Scarab Genomics Company Detail
Table 142. Scarab Genomics Business Overview
Table 143. Scarab Genomics Expression Competent Cells Product
Table 144. Scarab Genomics Revenue in Expression Competent Cells Business (2018-2023) & (US$ Million)
Table 145. Scarab Genomics Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Expression Competent Cells Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Expression Competent Cells Market Share by Type: 2022 VS 2033
Figure 3. Chemically Competent Cells Features
Figure 4. Electrocompetent Cells Features
Figure 5. Global Expression Competent Cells Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Expression Competent Cells Market Share by Application: 2022 VS 2033
Figure 7. Protein Expression Case Studies
Figure 8. Other Case Studies
Figure 9. Expression Competent Cells Report Years Considered
Figure 10. Global Expression Competent Cells Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Expression Competent Cells Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Expression Competent Cells Market Share by Region: 2022 VS 2033
Figure 13. Global Expression Competent Cells Market Share by Players in 2022
Figure 14. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Expression Competent Cells as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Expression Competent Cells Revenue in 2022
Figure 16. North America Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Expression Competent Cells Market Share by Country (2018-2033)
Figure 18. United States Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Expression Competent Cells Market Share by Country (2018-2033)
Figure 22. Germany Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Expression Competent Cells Market Share by Region (2018-2033)
Figure 30. China Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Expression Competent Cells Market Share by Country (2018-2033)
Figure 38. Mexico Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Expression Competent Cells Market Share by Country (2018-2033)
Figure 42. Turkey Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Expression Competent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Merck KGaA Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 46. Agilent Technologies Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 47. Takara Bio Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 48. Promega Corporation Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 49. Beijing TransGen Biotech Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 50. GeneScript Corporation Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 51. Yeastern Biotech Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 52. New England Biolabs Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 53. QIAGEN N.V. Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 54. OriGene Technologies Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 55. Lucigen Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 56. Zymo Research Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 58. Bioline Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 59. Delphi Genetics Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 60. IBA GmBH Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 61. Cell Applications Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 62. BioDynamics Laboratory Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 63. Scarab Genomics Revenue Growth Rate in Expression Competent Cells Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed